Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AstraZeneca
AstraZeneca
COVID-19 Cliff and Skyrocketing GLP-1 Drug Sales Highlight Q4 2023 Earnings
BioSpace
Sun, 02/11/24 - 03:50 pm
earnings
COVID-19
GLP-1 agonist
JNJ
Bristol Myers Squibb
Pfizer
AstraZeneca
Sanofi
Eli Lilly
Novo Nordisk
AstraZeneca’s year-end revenues rise but Wall Street remains unimpressed
Medical Marketing and Media
Thu, 02/8/24 - 11:23 am
AstraZeneca
earnings
COVID-19
AstraZeneca to invest $300 million in US facility for cell therapies
Reuters
Tue, 02/6/24 - 11:38 pm
AstraZeneca
cell therapy
AstraZeneca's phase 3 heart disease trial hits, teeing up Pfizer showdown in Japan
Fierce Biotech
Fri, 02/2/24 - 11:53 am
AstraZeneca
Pfizer
acoramidis
Japan
clinical trials
cardiomyopathy
ATTR-CM
AstraZeneca Case Leads Off Busy Year of Challenges to Medicare Drug Pricing Law
BioSpace
Thu, 02/1/24 - 10:51 pm
AstraZeneca
legal
Inflattion Reduction Act
Medicare
drug pricing
Sanofi expects RSV antibody to breach blockbuster status in 2024, even as supply hitch drags on
Fierce Pharma
Thu, 02/1/24 - 11:33 am
Sanofi
RSV
AstraZeneca
Beyfortus
Daiichi Sankyo again dials up Enhertu sales forecast, advances 2nd AstraZeneca-partnered ADC
Fierce Pharma
Wed, 01/31/24 - 10:27 pm
Daiichi Sankyo
AstraZeneca
Enhertu
earnings
As AstraZeneca gears up for courtroom showdown over IRA, Novo's case faces separate HHS rebuke
Fierce Pharma
Tue, 01/30/24 - 09:26 pm
AstraZeneca
Novo Nordisk
legal
Inflation Reduction Act
HHS
drug pricing
AstraZeneca, Daiichi aim for first pan-tumor ADC approval
BioPharma Dive
Mon, 01/29/24 - 11:25 am
AstraZeneca
Daiichi Sankyo
antibody-drug conjugate
Enhertu
pan-tumor
FDA
Incyte vets, with phase 1 within reach, raise $102M for new biotech to create better PARP, PI3K drugs
Fierce Biotech
Wed, 01/24/24 - 10:35 am
Synnovation Therapeutics
Incyte
AstraZeneca
GSK
Novartis
Pfizer
funding
cancer
PARP inhibitors
AstraZeneca reports positive data from Phase III trial of Imfinzi
Clinical Trials Arena
Mon, 01/22/24 - 11:29 am
AstraZeneca
Imfinzi
clinical trials
hepatocellular carcinoma
BioNTech challenges AstraZeneca with breast cancer precision drug trial
Reuters
Mon, 01/22/24 - 11:15 am
BioNTech
Duality Biologics
clinical trials
breast cancer
AstraZeneca
Daiichi Sankyo
HER2+ breast cancer
AZ bags first approval for PNH therapy danicopan, in Japan
Pharmaphorum
Fri, 01/19/24 - 09:38 am
AstraZeneca
Voydeya
PNH
danicopan
IRA lawsuits will be vital test of US’ ability to regulate pharma market
Clinical Trials Arena
Wed, 01/17/24 - 09:41 am
legal
Inflation Reduction Act
JNJ
AstraZeneca
HHS
drug pricing
Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference
Reuters
Fri, 01/5/24 - 11:25 am
M&A
JPMHC 2024
AbbVie
AstraZeneca
Bristol Myers Squibb
Carmot Therapeutics
Eli Lilly
AstraZeneca picks up a friend for Tagrisso in $40M upfront deal
Fierce Biotech
Tue, 01/2/24 - 10:05 pm
AstraZeneca
Allorion Therapeutics
lung cancer
Tagrisso
Biopharma Closes 2023 with Flurry of M&A Activity from AstraZeneca, BMS, Roche
BioSpace
Tue, 01/2/24 - 11:26 am
M&A
AstraZeneca
Gracell Biotechnologies
Bristol Myers Squibb
Rayze Bio
Roche
AZ, Sanofi’s Beyfortus cleared in China for RSV prevention
Pharmaphorum
Tue, 01/2/24 - 10:09 am
AstraZeneca
Sanofi
Beyfortus
RSV
vaccines
China
AstraZeneca to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases
BioSpace
Wed, 12/27/23 - 11:08 pm
AstraZeneca
Gracell
cell therapy
M&A
FDA approves Ionis-AstraZeneca's nerve disease drug
Reuters
Fri, 12/22/23 - 09:42 am
Ionis Pharmaceuticals
AstraZeneca
FDA
Wainua
ATTR-PN
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »